Navigation Links
A new method to localize the epileptic focus in severe epilepsy
Date:3/30/2011

The first two stereo-EEG explorations in Finland were carried out by neurosurgeons of the Epilepsy surgery team in Helsinki University Central Hospital this spring. The method reinforces other examination methods already in use and opens an excellent opportunity in the exploration of the electric activity of both the surface and the deep brain structures during epileptic seizures. The examination also enables exact localization of the functionally important areas of the brain and improves safety of epilepsy surgery at a later stage.

The stereo-EEG examination was developed already in the 1960's, but the recent modifications of the method in the last few years have made it safer and more feasible. The introduction of the method at HUCH benefits particularly patients with severe, drug resistant epilepsy

For the patient, the stereo-EEG is a considerably more pleasant experience than the earlier-used intracranial recording methods: no large craniotomy is required as thin recording electrodes are placed into the brain through small holes. The recording time can also be increased with the new method from one to as many as four weeks.

Epilepsy surgery in Finland has been centred in two university hospitals. In Helsinki University Central Hospital about 30 epilepsy surgery operations are performed each year, and the results are extremely good: more than half of the patients will be completely seizure-free thanks to the operation.

The new stereo-EEG method will be in active use.

"We have a large number of patients at the examination stage, and the ability to localize their epileptic foci through stereo-EEG is very beneficial. About a quarter of the presurgical patients will need an intracranial evaluation," neurosurgeon Atte Karppinen from HUCH Neurosurgery department informs.

Getting ready for Deep Brain Stimulation

HUCH neurosurgery clinic is also getting ready to introduce the so-called deep brain stimulation therapy. The equipment and methods used in the DBS and in the stereo-EEG follow the same basic principles. In HUCH they have several decades' experience and expertise in DBS surgery regarding other illnesses, such as Parkinson's disease.

"Starting DBS therapy in the treatment of epilepsy is well-founded at the stage when we have sufficient, reliable research-based information on the results of the method in the treatment of epilepsy," Dr Karppinen says.

"The methods we use complement each other, and our team's technical research facilities, expertise and results achieved by surgery represent the cutting edge in the whole world. We have all the knowhow and capacity for DBS surgery, but we proceed with patience."


'/>"/>

Contact: Dr. Atte Karppinen
atte.karppinen@hus.fi
358-504-272-522
University of Helsinki
Source:Eurekalert

Related biology news :

1. Commercial aquatic plants offer cost-effective method for treating wastewater
2. UC Riverside biochemists devise method for bypassing aluminum toxicity effects in plants
3. New lab manual focuses on essential methods for purifying and characterizing proteins
4. Deep biosphere research points to new methods for recovering petroleum
5. Fingerprinting method tracks mercury emissions from coal
6. Iowa State researcher develops new treatment method for canine eye diseases
7. New method provides panoramic view of protein-RNA interactions in living cells
8. Cold Spring Harbor Protocols features organ and cell culture methods
9. Engineer to present leak-proof method for carbon dioxide storage at international conference
10. Pitt researchers use fluorescence to develop method for detecting mercury in fish
11. New holographic method could be used for lab-on-a-chip technologies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/7/2017)... 2017 Zimmer Biomet Holdings, Inc. (NYSE and ... present at the LEERINK Partners 6th Annual Global Healthcare ... Wednesday, February 15, 2017 at 10 a.m. Eastern Time. ... can be accessed at http://wsw.com/webcast/leerink28/zbh .  The webcast ... Zimmer Biomet,s Investor Relations website at http://investor.zimmerbiomet.com . ...
(Date:2/3/2017)... 3, 2017  Texas Biomedical Research Institute announced that its ... Schlesinger as the Institute,s new President and CEO. Dr. ... 31, 2017. He is currently the Chair of the Department ... for Microbial Interface Biology at Ohio State University. ... President and CEO of Texas Biomed," said Dr. James ...
(Date:2/2/2017)... 2, 2017  EyeLock LLC, a market leader of ... paper " What You Should Know About Biometrics in ... user authenticity is a growing concern. In traditional schemes, ... However, traditional authentication schemes such as username/password suffer from ... authentication offers an elegant solution to the problem of ...
Breaking Biology News(10 mins):
(Date:2/22/2017)... ... February 22, 2017 , ... ... the leading medical education provider of women’s health, primary care, and specialty ... Council for Continuing Medical Education (ACCME). ACCME’s Accreditation with Commendation is a ...
(Date:2/22/2017)... Dublin - Research and Markets has ... Market-By Type, By Application, By End User, By Region, By Country: ... ... Market is forecasted to grow at a CAGR of 11.33% during ... crop protection market is driven by the surging demand for less ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... of Tom Perkins as European director. Operating from Pennside’s Zurich headquarters, Pennside Partners, ... , Perkins joins Pennside after more than a decade with leading market research ...
(Date:2/21/2017)... 21, 2017 /PRNewswire/ - SQI Diagnostics Inc. ("SQI" or the "Company") ... for the three months ended December 31, 2016. ... sciences and diagnostics company that develops and commercializes proprietary technologies ... ... on the commercial milestones achieved in fiscal 2016," said ...
Breaking Biology Technology: